PEG-MGF

PEG-MGF is a pegylated (polyethylene glycol-attached) form of Mechano Growth Factor (MGF), a splice variant of Insulin-like Growth Factor 1 (IGF-1), also referred to in the literature as the Ec/E peptide.

In research contexts it is classified as a growth factor peptide referenced in muscle-signaling studies, and the PEG chain is attached specifically to slow enzymatic breakdown once the material is in solution, extending its usable window for laboratory handling. Because the PEG modification changes the molecule's behavior in solution, PEG-MGF is treated as chemically distinct from unmodified MGF rather than interchangeable with it.

In short, PEG-MGF is a laboratory reference compound, not a supplement or finished product. The points below define it:

• Structure: a synthetic splice variant of IGF-1, known as MGF, with a polyethylene glycol chain attached to the peptide backbone.
• Category: listed in research literature as a growth factor peptide within the IGF-1 splice-variant family.
• Role of the PEG chain: a stability modification rather than an active ingredient on its own; it slows breakdown so the material holds up over a longer laboratory workflow.
• Supplied form: distributed to labs as a reference material for reconstitution, not as a ready-to-use solution.
• Regulatory status: not evaluated by the FDA, and supplied by Preppin Peppers strictly as a research-use reference subject, never as a product intended for human or animal use.

All of our reusable peptide pens (V1, V2, V3 and Gansulin) are compared on one page.

PEG-MGF is listed on PreppinPeppers as a reference entry for laboratory and research applications only; nothing here describes or implies human or animal use. This section covers reconstitution hardware compatibility rather than protocol or outcome, since those fall outside the scope of a research-use catalog.

When preparing a PEG-MGF vial with our kits, the same hardware rules apply as elsewhere in our catalog:

• Pen needles: our reusable pens accept universal 28G–33G screw-on pen needles.
• Cartridges: Our pens take standard 3 ml (300-unit) glass cartridges with the 11 mm long plunger (stopper), the cartridge we sell. 3 ml cartridges are also made with a shorter, about 8 mm plunger, and a pen is built for one height, so check that a cartridge from another source has the 11 mm long plunger before loading it; the glass looks identical from the outside.

We have not tested compatibility with third-party pens or cartridges, so fit outside our own hardware line cannot be confirmed. Always verify stopper depth before loading a cartridge.

What it is

PEG-MGF is a modified form of Mechano Growth Factor (MGF), a splice variant — a slightly different version built from the same gene — of Insulin-like Growth Factor 1 (IGF-1). In laboratory models, muscle tissue produces MGF in response to physical stress or injury, making it a subject of interest in mechanotransduction research.

The "PEG" in the name refers to polyethylene glycol, a chain of molecules conjugated to the MGF peptide. This conjugation acts like a protective coating, slowing the enzymatic processes that would otherwise break the peptide down quickly.

As a research reagent, this typically means the PEGylated form remains intact in solution for longer than the unmodified, native peptide — a relevant handling consideration when planning reconstitution and short-term storage. Researchers typically track this difference, PEGylated versus native peptide, when documenting handling and storage protocols for laboratory samples.

Research context and categorization

PEG-MGF is grouped as a growth factor peptide, meaning a small protein that signals cells to grow or repair. Researchers place it in the categories of tissue healing, tissue repair, and muscle signaling. In lab work, it comes up often in connection with satellite cell activation.

Satellite cells are special cells that sit on the outside of muscle fibers. They work like a repair crew, sitting idle until a fiber is damaged and then springing into action to help fix it.

Researchers have studied PEG-MGF to understand how it sends growth and repair signals in muscle-injury models (lab setups that mimic muscle damage). Scientists also use it to compare the MGF version of IGF-1 with the more common form of IGF-1 found throughout the body. Early-stage lab studies have looked at it in models of muscular dystrophy (a disease that weakens muscles over time), heart muscle repair, and wound healing.

All of this work is still investigational, meaning it is in the early stages of research only. PEG-MGF is not approved for use in humans or animals, and none of these findings count as confirmed or proven benefits.

Key point: PEG-MGF is an investigational compound intended strictly for laboratory research and is not approved for human or veterinary use.

Status

• Regulatory status: Research use only. The FDA (the U.S. agency that approves drugs and medical products) has not approved PEG-MGF for any purpose. It is not available by prescription and has not been tested in human clinical trials.
• Sport status: Banned. WADA (the World Anti-Doping Agency, which sets the drug rules for international sport) lists Mechano Growth Factors under class S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics), in the growth factors and growth factor modulators group. The ban applies at all times, including outside of competition. As a derivative (a modified form) of MGF, PEG-MGF falls under the same ban.

Reconstitution notes (general)

Reconstitution means dissolving the dry powder in liquid. The math is simple: concentration equals the milligrams of compound in the vial divided by the milliliters of water you add.

For example, if you add 2 mL of bacteriostatic water to a 2 mg vial, you get a solution of 1 mg/mL (one milligram of compound per milliliter of liquid). For other vial sizes, use the peptide calculator to find your target concentration.

• Diluent choice matters. Preservatives such as benzyl alcohol, common in bacteriostatic water, can interact with some reconstituted compounds over repeated draws — check the diluent's own documentation before pairing it with a given powder.
• Watch the solution, not just the clock. A color shift or cloudiness in a reconstituted solution is a visible sign of oxidation or degradation, regardless of how much time has passed. Treat that change as a cue to stop using the vial.

This is handling and storage information only.

Dilution and handling notes (compound-specific)

Preparation and Concentration

PEG-MGF arrives as a lyophilized (freeze-dried) powder. Freeze-drying pulls the water out under vacuum, leaving a dry powder cake. Researchers commonly dissolve this cake in bacteriostatic water, which is sterile water carrying a small amount of benzyl alcohol as a preservative, making it the usual choice for solutions meant to sit in storage for a few weeks rather than be used right away.

Reference material commonly cites a working concentration of around 1 mg/mL. A slightly acidic to neutral pH of roughly 6.5 to 7.5 helps the powder go into solution cleanly. (pH is a 0-14 scale describing how acidic or basic a liquid is; 7 is neutral, like pure water.)

For a 2 mg vial, a common approach adds 1 to 2 mL of bacteriostatic water, landing at roughly 2 mg/mL down to 1 mg/mL. More water lowers concentration and eases small-volume measuring; less water keeps total volume compact, up to the vial's physical capacity.

Benzyl Alcohol and Solution Stability

Benzyl alcohol does more than inhibit bacterial growth - it is also a mild solvent. In some peptide chemistries, prolonged exposure to it at room temperature, or repeated freeze-thaw cycling, can contribute to gradual breakdown of the compound. This differs from the aggregation described below, which shows up as visible cloudiness; solvent-related degradation is usually invisible to the eye. That is why reconstituted vials are generally kept refrigerated, shielded from light, and cycled through freeze-thaw as few times as possible.

Step-by-Step Reconstitution Process

1. Let the vial warm to room temperature for about 15 to 20 minutes before adding water. This reduces condensation (water droplets forming on the cold glass) and helps the powder dissolve evenly.
2. Add the water slowly. Aim the stream at the inside glass wall of the vial rather than squirting it straight down onto the powder cake.
3. Because of the attached PEG chain, the solution may feel slightly thick or viscous (like a very thin syrup). Let the vial sit still for a couple of minutes, then swirl or gently roll it until the liquid looks clear.
4. Do not shake or vortex (spin rapidly) the vial. Rough movement whips air into the liquid, creates foam, and can damage the peptide.
5. A properly dissolved vial should look clear. Cloudiness, haziness, or visible particles after mixing point to clumping (aggregation) or contamination. Discard the vial if you see any of these.
6. Avoid freezing and thawing the solution more than once. Repeated freeze-thaw cycles can break down both the peptide and the attached PEG chains.

Handling and storage

• Store the reconstituted (dissolved) solution refrigerated at 2 to 8 degrees Celsius (about 36 to 46 degrees Fahrenheit), protected from direct light.
• Wipe the rubber stopper with an alcohol swab before each puncture, and record the mixing date on the vial label.
• A refrigerated solution is generally considered usable for about a 4-week window. The diluent affects that timeline: preservative-containing diluents such as bacteriostatic water (which contains benzyl alcohol) behave differently in solution over time than preservative-free water, so treat 4 weeks as a general guide and always track your own mixing date.
• Discard the vial if the liquid turns cloudy, changes color, or shows floating particles or debris. A color or clarity shift generally signals oxidation from light, heat, or air exposure rather than normal variation.

Frequently asked questions